{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:19:09Z","timestamp":1791523149943,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.rdc.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T18:04:08Z","timestamp":1432145048000},"page":"367-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["The Pathogenesis of Systemic Sclerosis"],"prefix":"10.1016","volume":"41","author":[{"given":"Edward P.","family":"Stern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2015.04.002_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.rdc.2007.10.001","article-title":"Genetics and genomic studies in scleroderma (systemic sclerosis)","volume":"34","author":"Agarwal","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2015.04.002_bib2","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00002281-200011000-00007","article-title":"Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon","volume":"12","author":"Tan","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0889-857X(03)00015-2","article-title":"Systemic sclerosis: the susceptible host (genetics and environment)","volume":"29","author":"Tan","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2015.04.002_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0198-8859(94)00078-5","article-title":"HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies","volume":"42","author":"Morel","year":"1995","journal-title":"Hum Immunol"},{"key":"10.1016\/j.rdc.2015.04.002_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI115974","article-title":"Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis)","volume":"90","author":"Reveille","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rdc.2015.04.002_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.gene.6363734","article-title":"Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP","volume":"2","author":"Gilchrist","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.rdc.2015.04.002_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0002-9343(02)01069-0","article-title":"High prevalence of polymorphisms of angiotensin-converting enzyme (I\/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis","volume":"112","author":"Fatini","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib9","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/art.22036","article-title":"Endothelin axis polymorphisms in patients with scleroderma","volume":"54","author":"Fonseca","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa067655","article-title":"A\u00a0polymorphism in the CTGF promoter region associated with systemic sclerosis","volume":"357","author":"Fonseca","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/1529-0131(199810)41:10<1729::AID-ART5>3.0.CO;2-8","article-title":"Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population","volume":"41","author":"Tan","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib12","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.10601","article-title":"Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma","volume":"46","author":"Zhou","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib13","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","article-title":"The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype","volume":"18","author":"Rueda","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.rdc.2015.04.002_bib14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2009.118174","article-title":"BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians","volume":"69","author":"Rueda","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.04.002_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib16","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.rdc.2015.04.002_bib18","doi-asserted-by":"crossref","first-page":"e1002091","DOI":"10.1371\/journal.pgen.1002091","article-title":"Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis","volume":"7","author":"Allanore","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.rdc.2015.04.002_bib19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4049\/jimmunol.180.2.1060","article-title":"Polymorphisms in the CD3Z gene influence TCRzeta expression in systemic lupus erythematosus patients and healthy controls","volume":"180","author":"Gorman","year":"2008","journal-title":"J. Immunol"},{"key":"10.1016\/j.rdc.2015.04.002_bib20","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","article-title":"Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy","volume":"7","author":"Gorlova","year":"2011","journal-title":"PLoS Genet"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2015.04.002_bib21","first-page":"i159","article-title":"Defining Genetic Risk for Scleroderma Renal Crisis: A Genome-Wide Analysis of Anti-Rna Polymerase Antibody-Positive Systemic Sclerosis","volume":"54","author":"Guerra","year":"2015","journal-title":"Br Soc Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/occmed\/29.4.134","article-title":"Vinyl chloride: a review","volume":"29","author":"Binns","year":"1979","journal-title":"J\u00a0Soc Occup Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(83)91578-7","article-title":"Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride","volume":"1","author":"Black","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2015.04.002_bib24","first-page":"1059","article-title":"Genetic susceptibility to scleroderma-like syndrome in symptomatic and asymptomatic workers exposed to vinyl chloride","volume":"13","author":"Black","year":"1986","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2133.2006.07597.x","article-title":"Taxane-induced scleroderma","volume":"156","author":"Itoh","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(81)90949-1","article-title":"Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline","volume":"2","author":"Tabuenca","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2015.04.002_bib27","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199003293221302","article-title":"Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan","volume":"322","author":"Silver","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/1529-0131(199806)41:6<1111::AID-ART19>3.0.CO;2-J","article-title":"Is occupational organic solvent exposure a risk factor for scleroderma?","volume":"41","author":"Nietert","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2015.04.002_bib30","first-page":"97","article-title":"Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies","volume":"34","author":"Kettaneh","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/art.1780371119","article-title":"Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen","volume":"37","author":"Shi-Wen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib32","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1073\/pnas.86.21.8492","article-title":"Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis","volume":"86","author":"Maul","year":"1989","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2015.04.002_bib33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib34","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/art.27549","article-title":"Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies","volume":"62","author":"Shah","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib35","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2015.04.002_bib36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.rdc.2015.04.002_bib37","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(96)91687-6","article-title":"Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy","volume":"347","year":"1996","journal-title":"Lancet"},{"issue":"Suppl 4","key":"10.1016\/j.rdc.2015.04.002_bib38","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/ard.50.Suppl_4.866","article-title":"The endothelium: its role in scleroderma","volume":"50","author":"Pearson","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.04.002_bib39","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1529-0131(200008)43:8<1886::AID-ANR27>3.0.CO;2-S","article-title":"Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma","volume":"43","author":"Flavahan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM199508103330607","article-title":"Endothelins","volume":"333","author":"Levin","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.1780340807","article-title":"Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action","volume":"34","author":"Kahaleh","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib42","first-page":"1566","article-title":"Significance of plasma endothelin-1 levels in patients with systemic sclerosis","volume":"19","author":"Yamane","year":"1992","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib43","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets\u2013a marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s100670050132","article-title":"Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis","volume":"18","author":"Kobayashi","year":"1999","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.002_bib45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/qjmed\/hct111","article-title":"Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility","volume":"106","author":"Penn","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.rdc.2015.04.002_bib46","first-page":"1268","article-title":"Localization of endothelin-1 and its binding sites in scleroderma skin","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib47","first-page":"1693","article-title":"Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension","volume":"27","author":"Rolla","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib48","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1529-0131(200005)43:5<1085::AID-ANR19>3.0.CO;2-7","article-title":"Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1","volume":"43","author":"Andersen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/art.21543","article-title":"Variations of neuronal nitric oxide synthase in systemic sclerosis skin","volume":"54","author":"Ibba-Manneschi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI118377","article-title":"IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in\u00a0vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines","volume":"97","author":"Carvalho","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rdc.2015.04.002_bib51","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib52","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/art.21952","article-title":"Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies","volume":"54","author":"Ahmed","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib53","first-page":"402","article-title":"Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma)","volume":"27","author":"Sprott","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib54","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1161\/01.RES.0000077044.60138.7C","article-title":"Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species","volume":"92","author":"Grote","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.rdc.2015.04.002_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10067-007-0769-9","article-title":"Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis","volume":"27","author":"Riccieri","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2015.04.002_bib57","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1002\/art.22861","article-title":"Antiangiogenic plasma activity in patients with systemic sclerosis","volume":"56","author":"Mulligan-Kehoe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/346425a0","article-title":"Adhesion receptors of the immune system","volume":"346","author":"Springer","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2015.04.002_bib59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00002281-199911000-00010","article-title":"Abnormalities of adhesion molecules and chemokines in scleroderma","volume":"11","author":"Sato","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0190-9622(92)70165-C","article-title":"Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis","volume":"27","author":"Gruschwitz","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib61","first-page":"809","article-title":"Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus","volume":"20","author":"Carson","year":"1993","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib62","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/clin.1993.1100","article-title":"Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis","volume":"68","author":"Sfikakis","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.rdc.2015.04.002_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/qjmed\/91.8.561","article-title":"Different patterns of endothelial cell activation in renal and pulmonary vascular disease in scleroderma","volume":"91","author":"Stratton","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.rdc.2015.04.002_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.185.1.71","article-title":"Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis","volume":"185","author":"Casciola-Rosen","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib65","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","article-title":"Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis","volume":"46","author":"Chizzolini","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib66","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.04.002_bib67","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib68","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/ard.2002.004838","article-title":"Increased transendothelial migration of scleroderma lymphocytes","volume":"63","author":"Stummvoll","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.04.002_bib69","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib70","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199903183401102","article-title":"Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group","volume":"340","author":"Brent","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","article-title":"Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?","volume":"50","author":"Murata","year":"2008","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.rdc.2015.04.002_bib72","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.rdc.2015.04.002_bib73","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib74","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/eci.11.40","article-title":"Novel insights on the role of the innate immune system in systemic sclerosis","volume":"7","author":"York","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.rdc.2015.04.002_bib75","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-like receptor 4 signaling augments transforming growth factor-\u03b2 responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2015.04.002_bib76","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.1780340913","article-title":"Expression and function of surface antigens on scleroderma fibroblasts","volume":"34","author":"Abraham","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib77","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.1780370218","article-title":"Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud\u2019s phenomenon","volume":"37","author":"Higley","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2559.1994.tb01293.x","article-title":"Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders","volume":"24","author":"Corrin","year":"1994","journal-title":"Histopathology"},{"key":"10.1016\/j.rdc.2015.04.002_bib79","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/rheumatology\/kei088","article-title":"Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score","volume":"44","author":"Dziadzio","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2015.04.002_bib80","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/1529-0131(200103)44:3<731::AID-ANR124>3.0.CO;2-U","article-title":"Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma","volume":"44","author":"Kubo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib81","first-page":"885","article-title":"Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts","volume":"71","author":"McWhirter","year":"1994","journal-title":"Lab. Invest"},{"key":"10.1016\/j.rdc.2015.04.002_bib82","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1084\/jem.175.5.1227","article-title":"Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts","volume":"175","author":"Yamakage","year":"1992","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib83","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11926-002-0009-x","article-title":"Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis","volume":"4","author":"Leask","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2015.04.002_bib84","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hci078","article-title":"N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma","volume":"98","author":"Dziadzio","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.rdc.2015.04.002_bib85","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1074\/jbc.M511343200","article-title":"CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts","volume":"281","author":"Shi-wen","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.rdc.2015.04.002_bib86","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1152\/japplphysiol.00037.2010","article-title":"Interleukin-6: a growth factor stimulating collagen synthesis in human tendon","volume":"110","author":"Andersen","year":"2011","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.rdc.2015.04.002_bib87","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","article-title":"Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis","volume":"27","author":"Sato","year":"2001","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.rdc.2015.04.002_bib88","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archderm.1996.03890310088013","article-title":"Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis","volume":"132","author":"Salmon-Ehr","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib89","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor \u03b1, and interferon-\u03b3 levels in sera from patients with scleroderma","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib90","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/art.21497","article-title":"Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells","volume":"54","author":"Distler","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib91","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","article-title":"Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis","volume":"130","author":"Aden","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib92","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jaci.2005.09.035","article-title":"CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production","volume":"116","author":"Romagnani","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.rdc.2015.04.002_bib93","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib94","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/art.21396","article-title":"Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation","volume":"52","author":"Carulli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib95","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/1529-0131(199707)40:7<1237::AID-ART7>3.0.CO;2-Y","article-title":"Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis","volume":"40","author":"Shi-Wen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib96","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1523-1747.ep12560826","article-title":"Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization","volume":"90","author":"K\u00e4h\u00e4ri","year":"1988","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1988.tb01158.x","article-title":"Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization","volume":"18","author":"Scharffetter","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rdc.2015.04.002_bib98","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/jid.2008.171","article-title":"Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing","volume":"129","author":"Denton","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.rdc.2015.04.002_bib99","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1164\/rccm.201002-0279OC","article-title":"An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor \u03b2 receptor","volume":"183","author":"Hoyles","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2015.04.002_bib100","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1073\/pnas.79.4.1286","article-title":"Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors","volume":"79","author":"LeRoy","year":"1982","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2015.04.002_bib101","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib102","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/1529-0131(200108)44:8<1855::AID-ART324>3.0.CO;2-Q","article-title":"Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma)","volume":"44","author":"Wallis","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.04.002_bib103","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/art.20053","article-title":"Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen","volume":"50","author":"Lemaire","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X1500023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X1500023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:14:39Z","timestamp":1760181279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X1500023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":103,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0889857X1500023X"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Pathogenesis of Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}